The transcription factor Pax6 is widely expressed throughout the developing
nervous system, including most alar regions of the newly formed murine die
ncephalon, Later in embryogenesis its diencephalic expression becomes more
restricted. It persists in the developing anterior thalamus (conventionally
termed "ventral" thalamus) and pretectum but is downregulated in the body
of the posterior (dorsal) thalamus, At the time of this downregulation, the
dorsal thalamus forms its major axonal efferent pathway via the ventral te
lencephalon to the cerebral cortex. This pathway is absent in mice lacking
functional Pax6 (small eye homozygotes: Sey/Sey), We tested whether the mec
hanism underlying this defect includes abnormalities of the dorsal thalamus
itself, We exploited a new transgenic mouse ubiquitously expressing green
fluorescent protein tagged with tau, in which axonal tracts are clearly vis
ible, and co-cultured dorsal thalamic explants from Pax6(+/+) or Pax6(Sey/S
ey) embryos carrying the transgene with wild-type tissues from other region
s of the forebrain, Whereas Pax6(+/+) thalamic explants produced strong inn
ervation of wild-type ventral telencephalic explants in a pattern that mimi
cked the thalamocortical tract in vivo, Pax6(Sey/Sey) explants did not, ind
icating a defect in the ability of mutant dorsal thalamic cells to respond
to signals normally present in ventral telencephalon. Pax6(Sey/Sey) embryos
also showed early alterations in the expression of regulatory genes in the
region destined to become dorsal thalamus, Whereas in normal mice Nkx2.2 a
nd Lim1/Lhx1 are expressed ventral to this region, in the mutants their exp
ression domains are throughout it, suggesting that a primary action of Pax6
is to generate correct dorsoventral patterning in the diencephalon. Our re
sults suggest that normal thalamocortical development requires the actions
of Pax6 within the dorsal thalamus itself.